American Society of Hirudotherapy

Hirudotherapy in Wound Healing

Nair HKR, Ahmad NW, Lee HL, Ahmad N, Othamn S, Mokhtar NSHM, Chong SSY (2020) · The International Journal of Lower Extremity Wounds · n=3

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidence
Sample size of this trial compared with other diabetic-foot-ulcer trialsNayak S 200842Nair HKR 20203Katkar R 20251
This trial (highlighted) by sample size alongside other indexed diabetic-foot-ulcer trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-center case series of hirudotherapy for chronic wound management (Hospital Kuala Lumpur and Institute for Medical Research, Malaysia)
Sample size (n)
3
Intervention
Sterile medicinal leeches (Hirudinaria manillensis) applied to chronic wounds and pain sites until detached spontaneously; full sterile-technique protocol with non-tooth plastic forceps and biohazard disposal
Comparator
No randomized comparator - descriptive case series outcomes
Primary endpoint
Pain reduction, wound healing progression, and patient-reported balance/comfort outcomes
Primary result
All 3 patients showed improvements in their condition, especially reduction in pain and improvement in sense of balance; all wounds healed well; authors conclude hirudotherapy is effective but note small sample size and need for more robust trials to establish significance
Follow-up duration
until wound resolution

Key Findings

  • Malaysian hospital-based case series documenting hirudotherapy protocols using Hirudinaria manillensis (Asian medicinal leech)
  • All three patients reported pain reduction and improvement in balance/comfort metrics
  • Detailed sterile-technique and biohazard-disposal protocol documented
  • Authors explicitly call for larger, more robust trials to confirm significance
  • Uses a different leech species (H. manillensis) than the European H. medicinalis - adds species coverage to the literature

Limitations

  • Very small case series (n=3) - hypothesis-generating only
  • No randomized control or sham comparison
  • Mixed wound etiologies in the case series limit attribution to specific pathology
  • Different leech species (Hirudinaria manillensis) not FDA-cleared in the US
  • Outcomes assessed by treating clinicians without standardized blinded scoring

Clinical Implications

Nair 2020 documents the Malaysian government-hospital approach to hirudotherapy for chronic wound healing using a non-European leech species (Hirudinaria manillensis). For US clinicians, the species difference limits direct applicability under the FDA K040187 clearance framework, which specifies whole-leech H. medicinalis. The case series provides useful operational documentation of sterile-technique and biohazard-disposal protocols but cannot establish efficacy at any meaningful evidence level. The trial supports calls for larger species-specific RCTs in chronic wound healing.

Related Trials

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.